XO SCORE® and XO CROSS® are now FDA Cleared
Ultra-low-profile one-piece metal alloy micro and support catheters that deliver class-leading performance and specs.
TARGET TREATMENT & APPLICATIONS
PERIPHERAL ARTERY DISEASE (PAD)
PAD affects 12M in the US and 200M+ globally. Increasingly complex interventions and advanced disease states require novel technologies and tools to improve the quality of care for patients. The XO Score and XO Cross platforms have been designed and optimized for dilatation and access of tough calcified lesions in the peripheral vasculature.
END-STAGE RENAL DISEASE (ESRD)
More than 650k US and 2M+ global patients receive dialysis treatment each year. A high rate of arteriovenous fistulas and grafts fail due to excessive intimal hyperplasia-related stenoses. Dialysis interventions often require extreme high-pressure angioplasty to salvage access sites and restore flow. XO Score was designed to effectively dilatate tough, fibrous lesions encountered during fistula and graft maintenance.